Active Pharmaceutical Ingredients (API) Market Overview
Any substance or mixture of substances used in a finished pharmaceutical product (FPP) that is intended to provide pharmacological action or otherwise have a direct impact in the diagnosis, remedy, mitigation, therapy, or prevention of disease, or to have a direct effect in repairing, correcting, or altering physiological functions in humans is referred to as an active pharmaceutical ingredient (API).
The global active pharmaceutical ingredients (API) market is being driven by an increase in the incidence of chronic diseases. According to the International Diabetes Federation, 463 million individuals were diagnosed with diabetes worldwide in 2023. Furthermore, by 2030, the number of new cancer cases is predicted to rise to 23.6 million each year. Aside from cancer, the prevalence of a variety of other diseases has increased. The active pharmaceutical ingredients (API) market is being driven by an increase in the prevalence of cancer, cardiovascular illnesses, and diabetes, as well as an increase in the geriatric population.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Drug Type, API Type, End User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer, Inc., Novartis AG, Mylan N.V., Lonza, WuXi AppTec Co., Ltd., Piramal Pharma Solutions, Hisun USA, Inc., Ipca Laboratories Ltd., AbbVie, Inc., Alembic Pharmaceuticals Limited, BASF SE, Biocon Ltd. |
Covid-19 Impact on Active Pharmaceutical Ingredients (API) Market
In addition, the current Active Pharmaceutical Ingredients (API) Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Active Pharmaceutical Ingredients (API) Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Active Pharmaceutical Ingredients (API) Market Segment Overview
According to Drug Type, the Branded or Innovative Prescription Drugs segment dominated the global active pharmaceutical ingredients (API) market in terms of revenue in 2020. Furthermore, By API Type, the synthetic is one of the largest segments in the market. By End User, the pharmaceutical & biotechnological industry segment holds the largest share of the market.
Active Pharmaceutical Ingredients (API) Market, By Drug Type
· Branded or Innovative Prescription Drugs
· Generic Prescription Drugs
· Over-The-Counter (OTC) Drugs
Active Pharmaceutical Ingredients (API) Market, By API Type
· Synthetic
· Biological
· Plant Extracts
Active Pharmaceutical Ingredients (API) Market, By End User
· Pharmaceutical & Biotechnological Industry
· CROs
· CMOs
· Others
Active Pharmaceutical Ingredients (API) Regional Overview
The global Active Pharmaceutical Ingredients (API) Market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is the most prominent region for the global Active Pharmaceutical Ingredients (API) Market. In the Asia Pacific, lung cancer is the main cause of cancer death. China alone is responsible for more than half of all cancer cases in the region. Cervical cancer is caused by changes in lifestyle and socio-cultural factors. India, Thailand, and China are three of the most affected countries in the Asia Pacific by breast cancer.
Active Pharmaceutical Ingredients (API) Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Active Pharmaceutical Ingredients (API) Market, Key Players
· Merck & Co., Inc.
· Teva Pharmaceutical Industries Ltd.
· Sanofi
· Pfizer, Inc.
· Novartis AG
· Mylan N.V.
· Lonza
· WuXi AppTec Co., Ltd.
· Piramal Pharma Solutions
· Hisun USA, Inc.
· Ipca Laboratories Ltd.
· AbbVie, Inc.
· Alembic Pharmaceuticals Limited
· BASF SE
· Biocon Ltd.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Active Pharmaceutical Ingredients (API) market?
The global active pharmaceutical ingredients (API) market is being driven by an increase in the incidence of chronic diseases.
Q2. Which Segments are covered in the global Active Pharmaceutical Ingredients (API) market report?
Drug Type, API Type, End User, and Region. these segments are covered in the global Active Pharmaceutical Ingredients (API) market report
Q3. Which segment is projected to hold the largest share in the global Active Pharmaceutical Ingredients (API) market. ?
Branded or Innovative Prescription Drugs segment is projected to hold the largest share in the global Active Pharmaceutical Ingredients (API) market.
Q4. Which region holds the largest share in the global Active Pharmaceutical Ingredients (API) market?
Asia Pacific holds the largest share in the global Active Pharmaceutical Ingredients (API) market.
Q5. Which are the prominent players in the global Active Pharmaceutical Ingredients (API) market?
Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer, Inc., Novartis AG, Mylan N.V., Lonza, WuXi AppTec Co., Ltd., Piramal Pharma Solutions, Hisun USA, Inc., Ipca Laboratories Ltd., AbbVie, Inc., Alembic Pharmaceuticals Limited, BASF SE, Biocon Ltd. are some key players in the global Active Pharmaceutical Ingredients (API) market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Active Pharmaceutical Ingredients (API) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Drug Type
- 5.2.1. Branded or Innovative Prescription Drugs
- 5.2.2. Generic Prescription Drugs
- 5.2.3. Over-The-Counter (OTC) Drugs
- 5.3. Market Analysis, Insights and Forecast – By API Type
- 5.3.1. Synthetic
- 5.3.2. Biological
- 5.3.3. Plant Extracts
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Pharmaceutical & Biotechnological Industry
- 5.4.2. CROs
- 5.4.3. CMOs
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Active Pharmaceutical Ingredients (API) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Drug Type
- 6.2.1. Branded or Innovative Prescription Drugs
- 6.2.2. Generic Prescription Drugs
- 6.2.3. Over-The-Counter (OTC) Drugs
- 6.3. Market Analysis, Insights and Forecast – By API Type
- 6.3.1. Synthetic
- 6.3.2. Biological
- 6.3.3. Plant Extracts
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Pharmaceutical & Biotechnological Industry
- 6.4.2. CROs
- 6.4.3. CMOs
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Active Pharmaceutical Ingredients (API) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Drug Type
- 7.2.1. Branded or Innovative Prescription Drugs
- 7.2.2. Generic Prescription Drugs
- 7.2.3. Over-The-Counter (OTC) Drugs
- 7.3. Market Analysis, Insights and Forecast – By API Type
- 7.3.1. Synthetic
- 7.3.2. Biological
- 7.3.3. Plant Extracts
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Pharmaceutical & Biotechnological Industry
- 7.4.2. CROs
- 7.4.3. CMOs
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Active Pharmaceutical Ingredients (API) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Drug Type
- 8.2.1. Branded or Innovative Prescription Drugs
- 8.2.2. Generic Prescription Drugs
- 8.2.3. Over-The-Counter (OTC) Drugs
- 8.3. Market Analysis, Insights and Forecast – By API Type
- 8.3.1. Synthetic
- 8.3.2. Biological
- 8.3.3. Plant Extracts
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Pharmaceutical & Biotechnological Industry
- 8.4.2. CROs
- 8.4.3. CMOs
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Active Pharmaceutical Ingredients (API) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Drug Type
- 9.2.1. Branded or Innovative Prescription Drugs
- 9.2.2. Generic Prescription Drugs
- 9.2.3. Over-The-Counter (OTC) Drugs
- 9.3. Market Analysis, Insights and Forecast – By API Type
- 9.3.1. Synthetic
- 9.3.2. Biological
- 9.3.3. Plant Extracts
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Pharmaceutical & Biotechnological Industry
- 9.4.2. CROs
- 9.4.3. CMOs
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Merck & Co., Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Teva Pharmaceutical Industries Ltd.
- 10.6. Sanofi
- 10.7. Pfizer, Inc.
- 10.8. Novartis AG
- 10.9. Mylan N.V.
- 10.10. Lonza
- 10.11. WuXi AppTec Co., Ltd.
- 10.12. Piramal Pharma Solutions
- 10.13. Hisun USA, Inc.
- 10.14. Ipca Laboratories Ltd.
- 10.15. AbbVie, Inc.
- 10.16. Alembic Pharmaceuticals Limited
- 10.17. BASF SE
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
